rig-3 Antibody

Shipped with Ice Packs
In Stock

Description

Molecular Characterization of RIG-3

RIG-3 is a glycosylphosphatidylinositol (GPI)-anchored protein expressed in neurons. Key features include:

  • Domain structure: Immunoglobulin (Ig) domains and fibronectin type III (FNIII) repeats.

  • Function: Modulates acetylcholine receptor (AChR) clustering at neuromuscular junctions (NMJs) and regulates Wnt signaling via interactions with CAM-1, a Ror-type receptor tyrosine kinase .

Role in Synaptic Plasticity

  • Aldicarb hypersensitivity: rig-3 mutants exhibit heightened sensitivity to aldicarb, a cholinesterase inhibitor, due to increased AChR density at NMJs .

  • Post-synaptic potentiation: RIG-3 loss amplifies endogenous excitatory postsynaptic currents (EPSCs) and exogenous ACh-activated currents in body-wall muscles .

Regulation of Wnt Signaling

  • CAM-1 inhibition: RIG-3 binds CAM-1 to suppress Wnt ligand activity, maintaining neuronal polarity and synaptic stability .

  • Phenotypic rescue: Expression of RIG-3 in cholinergic neurons restores normal aldicarb sensitivity and AChR levels in mutants .

Experimental Use of RIG-3 Antibodies

Though not commercially available, custom antibodies have been critical in:

  • Localization studies: Immunostaining confirmed RIG-3 expression in C. elegans motor neurons and ALM mechanosensory neurons .

  • Functional assays: Antibodies validated RIG-3’s GPI anchoring and its role in ribosome assembly during Nf-κb1 mRNA translation .

Comparative Analysis of rig-3 Mutants vs. Wild Type

ParameterWild Typerig-3 Mutant
Aldicarb sensitivityNormalHypersensitive
Muscle AChR densityBaselineIncreased
Neuronal polarity defectsAbsentPresent
Wnt signaling activityRegulatedHyperactive

Implications for Human Biology

While RIG-3 is not directly conserved in mammals, its regulatory mechanisms offer insights into:

  • Neurodegenerative diseases: Dysregulated synaptic plasticity in Alzheimer’s and Parkinson’s .

  • Cancer metastasis: Wnt signaling pathways targeted by RIG-3 homologs .

Limitations and Future Directions

  • Antibody availability: Lack of commercial RIG-3 antibodies limits broader application.

  • Therapeutic potential: Engineered antibodies targeting RIG-3-like pathways could modulate Wnt signaling in disease models .

Product Specs

Buffer
Preservative: 0.03% ProClin 300
Constituents: 50% Glycerol, 0.01M PBS, pH 7.4
Form
Liquid
Lead Time
Made-to-order (14-16 weeks)
Synonyms
rig-3 antibody; C53B7.1 antibody; Neuronal immunoglobulin domain-containing protein rig-3 antibody
Target Names
rig-3
Uniprot No.

Target Background

Function
RIG-3 is a cell surface protein implicated in the modulation of cholinergic synapse plasticity at neuromuscular junctions and in the polarity of the ALM mechanosensory neuron. Its mechanism of action may involve antagonism of Wnt signaling.
Gene References Into Functions
  • RIG-3 inhibits Wnt/LIN-44 signaling through interaction with CAM-1. PMID: 28515212
  • Studies indicate that RIG-3 regulates Wnt signaling and exhibits an anti-plasticity function, preventing activity-dependent alterations in postsynaptic receptor fields. PMID: 21745641
Database Links

KEGG: cel:CELE_C53B7.1

STRING: 6239.C53B7.1

UniGene: Cel.6793

Subcellular Location
Cell projection, axon. Cell junction, synapse. Cell membrane; Lipid-anchor, GPI-anchor.
Tissue Specificity
Expressed in the cholinergic motor neurons AS, VA and DA in the ventral nerve cord and in the mechanosensory ALM neurons in the midbody.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.